The editors of the Journal of Hematology Oncology Pharmacy (JHOP) are excited to share a resource designed to assist patients and caregivers in managing common and rare side effects associated with antibody–drug conjugate (ADC) therapy, particularly for metastatic breast cancer. This infographic will provide clear, actionable insights and practical tips into recognizing, monitoring, and addressing these side effects. This guide is intended to empower patients and caregivers with the knowledge to proactively address side effects while collaborating closely with their healthcare teams through the treatment journey.
Related Items
This case-based exchange features Tajuana Bradley, MS, FNP-C, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discussing their best practices for a patient with metastatic breast cancer treated with antibody-drug conjugate therapy.
This article will highlight common and serious adverse events (AEs) to be aware of when treating patients with antibody–drug conjugate therapy, as well as provide commentary from Tajuana Bradley, MS, FNP-BC, on key points of intervention when resolving these AEs and supporting patients through the treatment journey.
This article explores the pharmacist’s vital role in mitigating adverse events, enhancing patient adherence, and optimizing therapeutic outcomes in patients being treated with antibody–drug conjugate therapies.
